1. Home
  2. Licogliflozin

Contact Angene

Tel: +852 8191 6999

Email: [email protected]

Brc1cnc(nc1)C
Pyrimidine, 5-bromo-2-methyl-
CCCP1(=O)OP(=O)(CCC)OP(=O)(O1)CCC
1,3,5,2,4,6-Trioxatriphosphorinane, 2,4,6-tripropyl-, 2,4,6-trioxide
CC1(C)OB(OC1(C)C)B1OC(C(O1)(C)C)(C)C
2,2'-Bi-1,3,2-dioxaborolane, 4,4,4',4',5,5,5',5'-octamethyl-
O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.[Pd].[Pd]
Tris(dibenzylideneacetone)dipalladium
C1CCC(CC1)P(C1CCCCC1)C1CCCCC1.Cc1cc(C)c(c(c1)C)N1CCN(C1=[Ru](=Cc1ccccc1)(Cl)Cl)c1c(C)cc(cc1C)C
Ruthenium,[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(phenylmethylene)(tricyclohexylphosphine)-, (SP-5-41)-

Licogliflozin

OC[C@H]1O[C@@H](c2ccc(c(c2)Cc2ccc3c(c2)OCCO3)CC)[C@@H]([C@H]([C@@H]1O)O)O Request for Quotation
Chemical Name: Licogliflozin
CAS Number: 1291094-73-9
Product Number: AG01EOH8(AGN-PC-3H46DI)
Synonyms:
MDL No:
Molecular Formula: C23H28O7
Molecular Weight: 416.4642

Identification/Properties

Computed Properties
Molecular Weight:
416.47g/mol
XLogP3:
1.9
Hydrogen Bond Donor Count:
4
Hydrogen Bond Acceptor Count:
7
Rotatable Bond Count:
5
Exact Mass:
416.184g/mol
Monoisotopic Mass:
416.184g/mol
Topological Polar Surface Area:
109A^2
Heavy Atom Count:
30
Formal Charge:
0
Complexity:
546
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
5
Undefined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
1
Compound Is Canonicalized:
Yes

Safety Information

NMR Spectrum

Other Analytical Data

Request for Quotation

Customer Feedback

Chemical Structure


Licogliflozin is a potent and selective sodium-glucose cotransporter 2 (SGLT2) inhibitor that has found widespread application in chemical synthesis processes. This compound plays a crucial role in the development of new pharmaceutical products by serving as a key building block in the synthesis of various drug candidates. Licogliflozin functions by blocking the reabsorption of glucose in the kidneys, leading to its excretion in the urine. In chemical synthesis, this property of Licogliflozin can be harnessed to facilitate the creation of novel molecules with potential therapeutic benefits. By incorporating Licogliflozin into the synthetic pathways of drug compounds, chemists can design more effective treatments for conditions such as diabetes and obesity. The unique mechanism of action of Licogliflozin makes it a versatile tool in the hands of synthetic chemists, allowing for the synthesis of diverse molecules with enhanced biological activities. Additionally, the high potency and selectivity of Licogliflozin ensure that the resulting synthesized compounds exhibit desirable pharmacological properties, making it an invaluable asset in the field of medicinal chemistry.